V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007746 | 310004926 | null | 61.1 | Curative (C) | 2015-06-17 | 2015-09-09 | Cisplatin 100 + RT(H&N) 1 day | N | N | 310019421 | CISPLATIN + RT |
| 310007747 | 310004926 | 1.26 | 75.7 | Disease modification (D) | 2015-08-10 | 2015-08-10 | Rituximab | N | N | 310019421 | RITUXIMAB |
| 310007748 | 310004927 | null | 94 | Curative (C) | 2014-09-02 | 2014-12-18 | GDP | N | null | 310019427 | GDP |
| 310007749 | 310004929 | 1.72 | 87.2 | Curative (C) | 2013-04-17 | 2013-04-17 | Methotrexate intrathecal | N | N | 310019427 | METHOTREXATE INTRATHECAL |
| 310007750 | 310008131 | null | 84.4 | Palliative (P) | 2017-09-06 | 2017-09-18 | ESHAP | null | Y | 310019432 | CARBOPLATIN + ETOPOSIDE |
| 310007751 | 310008131 | 1.7 | 68 | Curative (C) | 2016-07-20 | 2016-09-18 | Cisplatin | N | N | 310019432 | CISPLATIN |
| 310007752 | 310011555 | 1.6 | 56.4 | Adjuvant (A) | 2016-12-09 | 2016-12-09 | Bexarotene | N | N | 310019446 | BEXAROTENE |
| 310007753 | 310011732 | 1.83 | 110 | Palliative (P) | 2015-03-01 | 2015-06-26 | Docetaxel 75mg/m2 (21 day) | 02 | N | 310019449 | DOCETAXEL |
| 310007754 | 310011732 | 1.62 | 60.5 | Curative (C) | 2015-06-03 | 2015-07-01 | Docetaxel 75mg/m2 (21 day) | 02 | N | 310019449 | DOCETAXEL |
| 310007755 | 310011732 | 1.4 | 48.3 | Palliative (P) | 2018-01-05 | 2018-01-17 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | null | N | 310019449 | DOCETAXEL + GEMCITABINE |
| 310007756 | 310011732 | 1.76 | 86.7 | Palliative (P) | 2015-12-28 | 2016-01-03 | GDP | 02 | Y | 310019449 | GDP |
| 310007757 | 310008133 | 1.74 | null | Palliative (P) | 2013-04-11 | 2013-06-24 | CHOP R - 21 days | N | N | 310019462 | CHOP R |
| 310007758 | 310004936 | 1.65 | 71.3 | Disease modification (D) | 2013-10-22 | 2013-11-28 | CYCLOPHOSPHAMIDE | 02 | N | 310019463 | CYCLOPHOSPHAMIDE |
| 310007759 | 310004938 | 1.69 | 77.5 | Neo-adjuvant (N) | null | 2013-07-26 | CARBOPLATIN + ETOPOSIDE | 2 | N | 310019464 | ESHAP |
| 310007760 | 310004939 | 1.6 | 68.3 | Curative (C) | 2015-07-23 | 2015-08-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310019466 | CARBOPLATIN + ETOPOSIDE |
| 310007761 | 310004942 | 1.71 | 72 | null | 2014-06-17 | 2014-12-14 | Bexarotene | N | N | 310019467 | BEXAROTENE |
| 310007762 | 310004944 | 1.84 | null | Palliative (P) | 2015-07-01 | 2015-07-15 | CHOP R - 14 days | 02 | null | 310019470 | CHOP R |
| 310007763 | 310008137 | 1.58 | 46.65 | Palliative (P) | 2015-04-01 | 2015-04-04 | Cisplatin | 02 | N | 310019473 | CISPLATIN |
| 310007764 | 310008139 | 1.4 | 75 | Palliative (P) | 2013-04-14 | 2013-06-20 | Bexarotene | N | null | 310019476 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007765 | 310004950 | 1.57 | 71 | Palliative (P) | 2017-10-02 | 2017-10-02 | Ipilimumab | N | N | 310019477 | IPILIMUMAB |
| 310007766 | 310004953 | 1.73 | null | Curative (C) | 2016-02-16 | 2016-02-17 | Cisplatin | N | N | 310019481 | CISPLATIN |
| 310007767 | 310004954 | null | 71.5 | Adjuvant (A) | 2013-10-09 | 2013-10-10 | Bexarotene | N | null | 310019484 | UKALL2011 |
| 310007768 | 310009830 | 1.78 | 68 | Palliative (P) | 2015-09-14 | 2016-02-22 | Bexarotene | 02 | N | 310019484 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007769 | 310004955 | null | 51 | Disease modification (D) | 2016-02-23 | 2017-05-19 | CARBOPLATIN + ETOPOSIDE | N | N | 310019507 | BEXAROTENE |
| 310007770 | 310004958 | 1.59 | 74 | Disease modification (D) | 2017-03-09 | 2017-03-09 | ETOPOSIDE | Y | Y | 310019511 | ETOPOSIDE |
| 310007771 | 310008146 | 1.71 | 22.4 | null | 2013-12-06 | 2014-03-01 | Ipilimumab | N | N | 310019511 | IPILIMUMAB |
| 310007772 | 310004960 | 1.84 | 76 | Not known (9) | 2013-08-21 | 2013-12-23 | Cisplatin | N | N | 310019517 | CISPLATIN |
| 310007773 | 310004960 | 1.74 | 91.7 | Palliative (P) | 2014-04-04 | 2014-08-09 | Ipilimumab | N | N | 310019517 | IPILIMUMAB |
| 310007774 | 310004960 | 1.47 | 72 | Palliative (P) | 2015-03-28 | 2015-04-26 | Capecitabine + Oxaliplatin 21day | 02 | N | 310019517 | EOX |
| 310007775 | 310004960 | 1.64 | null | Palliative (P) | 2017-08-21 | 2017-08-26 | MPT | N | N | 310019517 | TRABECTEDIN |
| 310007776 | 310011274 | 1.69 | 73 | Curative (C) | 2018-07-05 | 2018-08-07 | Cyclophosphamide Fludarabine (Oral) | Y | N | 310019538 | CVP R |
| 310007777 | 310011274 | 1.67 | 90.2 | Curative (C) | 2016-11-06 | 2016-11-06 | AXITINIB | N | N | 310019538 | IVE + METHOTREXATE |
| 310007778 | 310004962 | 1.83 | 53.6 | Curative (C) | 2014-01-03 | 2014-03-07 | R GCVP | 2 | N | 310019539 | AZACITIDINE |
| 310007779 | 310004962 | 1.57 | 83.3 | Palliative (P) | 2017-11-23 | 2017-12-17 | Capecitabine (21days) + Carboplatin | null | N | 310019539 | SUNITINIB |
| 310007780 | 310004965 | 1.76 | 69.6 | Disease modification (D) | null | 2017-09-07 | ICE | N | N | 310019545 | POMALIDOMIDE |
| 310007781 | 310008151 | 1.8 | 0 | Curative (C) | 2016-09-16 | 2016-09-16 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 310019545 | TRABECTEDIN |
| 310007782 | 310008152 | null | null | Curative (C) | 2016-08-14 | 2016-08-14 | MTX HD + PROCARBAZINE + VINCRISTINE | N | N | 310019551 | BCG |
| 310007783 | 310004968 | 1.54 | 84 | Palliative (P) | 2015-10-31 | 2015-11-25 | Oxaliplatin + Modified de Gramont | N | N | 310019558 | ICON TRIAL |
| 310007785 | 310008156 | 1.62 | 72 | Curative (C) | null | 2017-10-04 | Capecitabine + Oxaliplatin 21day | 2 | N | 310019563 | INTERFERON |
| 310007786 | 310004975 | 1.72 | null | Curative (C) | 2016-10-10 | 2017-07-18 | CODOX M | N | N | 310019567 | R IVAC |
| 310007787 | 310004976 | 1.71 | 83.3 | Palliative (P) | 2016-12-18 | 2016-12-25 | Methotrexate + Folinic acid | 2 | N | 310019567 | METHOTREXATE HIGH DOSE |
| 310007788 | 310010755 | 1.61 | 78.3 | Palliative (P) | 2018-04-19 | 2018-06-02 | Sunitinib | 02 | N | 310019570 | CEV |
| 310007789 | 310010755 | 0 | 69.6 | Neo-adjuvant (N) | 2015-09-03 | 2015-09-03 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 310019570 | MELPHALAN + TOPOTECAN |
| 310007790 | 310004979 | 1.69 | null | Curative (C) | 2015-05-04 | 2015-06-03 | ECX | null | null | 310019575 | BCG |
| 310007791 | 310008160 | 1.76 | 0 | Palliative (P) | 2017-06-11 | 2017-10-15 | Temozolomide 200mg/m2 | N | N | 310019580 | TRABECTEDIN |
| 310007792 | 310008161 | 1.69 | 77 | Curative (C) | 2014-03-02 | 2014-03-03 | RCEOP | N | N | 310019583 | ALEMTUZUMAB |
| 310007793 | 310008163 | 1.78 | 74.2 | Curative (C) | 2017-05-31 | 2017-06-17 | STS Rhabdomyosarcoma RMS 2005 VA | N | N | 310019585 | TRABECTEDIN |
| 310007794 | 310011733 | 1.61 | 58 | Curative (C) | 2015-12-06 | 2015-12-10 | Eribulin | 2 | N | 310019592 | TRIPLE INTRATHECAL |
| 310007795 | 310011834 | 1.61 | 74.1 | Palliative (P) | 2015-07-11 | 2015-07-18 | Bendamustine + prednisolone | 02 | N | 310019596 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 310007796 | 310011834 | 1.78 | 79.2 | Curative (C) | 2013-08-16 | 2013-10-27 | ALEMTUZUMAB + FLUDARABINE | 02 | N | 310019596 | CARBOPLATIN + DOCETAXEL |